Eltrombopag
Information about Eltrombopag
Eltrombopag Uses
Eltrombopag is used for chronic idiopathic thrombocytopenia and low platelet count due to ITP or HCV infection. It is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic
purpura (ITP) or chronic hepatitis C virus (HCV) infection. It’s also used to treat severe aplastic anemia.
How Eltrombopag works
Eltrombopag is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.
Available Medicine for Eltrombopag
RevoladeNovartis India Ltd
₹1 to ₹151942 variant(s)
TrombonatNatco Pharma Ltd
₹1400 to ₹25002 variant(s)
ElpagShilpa Medicare Ltd
₹835 to ₹16502 variant(s)
RebopagMSN Laboratories
₹1500 to ₹52003 variant(s)
CelbopagCelon Laboratories Ltd
₹1234 to ₹23042 variant(s)
ThromplatAureate Healthcare Pvt Ltd
₹2500 to ₹45002 variant(s)
EltrocibLucien Life Sciences Private Limited
₹1290 to ₹25002 variant(s)
EltrogGlenmark Pharmaceuticals Ltd
₹800 to ₹15002 variant(s)
EltromagCipla Ltd
₹489 to ₹9792 variant(s)
ElboromBDR Pharmaceuticals Internationals Pvt
₹1350 to ₹23402 variant(s)
Expert advice for Eltrombopag
- Take Eltrombopag on an empty stomach, either 1 hour before or 2 hours after meals.
- Take Eltrombopag at least 2 hours before or 4 hours after eating dairy products and calcium-fortified juices.